文献速递主动脉疾病内脏/肾动脉与血管畸形

慢性胸腹主动脉夹层动脉瘤的腔内分期修复:4例病例系列

Endovascular Aortic Repair for Progressive Chronic Thoracoabdominal Aortic Dissections.
PubMed 文献 · Ann Vasc Surg · 2017-03-22

该病例系列纳入2010年1月至2015年5月间4例既往有高血压、初始表现为主动脉夹层、后续发展为降主动脉瘤的患者,均采用TEVAR序贯FEVAR的全腔内方式治疗。所有手术结束时分支内脏血管均通畅且无I型内漏,但需多次复杂手术,并出现需再次干预的并发症。

要点

  • 夹层后胸腹主动脉瘤可用TEVAR序贯FEVAR的全腔内方式完成修复
  • 本系列所有手术结束时分支内脏血管通畅且无I型内漏
  • 此类治疗需多次手术和多种复杂新技术,需关注围术期并发症

核心结论

  • 对进展性慢性胸腹主动脉夹层动脉瘤,采用TEVAR序贯FEVAR的全腔内途径在4例中实现了分支内脏血管通畅且无I型内漏。

研究设计与样本

  • 经机构审查委员会批准,回顾性识别2010年1月至2015年5月间4例 pretreatment 高血压、初始表现为主动脉夹层并后续出现降主动脉瘤、接受TEVAR与FEVAR治疗的患者,按月与按年分析结局。

主要发现

  • 原文背景指出升主动脉与胸主动脉夹层有20-40%进展为胸腹主动脉瘤。
  • 所有手术结束时分支内脏血管通畅且无I型内漏。
  • 1例需取出急性期为内脏再灌注置入的逆行肠系膜上动脉支架。
  • 1例术后即刻出现右股总动脉急性血栓栓塞性闭塞,需急诊血运重建。

关键数值与推荐

  • 原文背景数值:升主动脉与胸主动脉夹层进展为胸腹主动脉瘤的比例为20-40%。
  • 本系列4例均以TEVAR序贯FEVAR完成治疗。

临床怎么用

  • 对夹层后慢性扩张性胸腹主动脉瘤,可考虑以TEVAR序贯FEVAR的全腔内策略替代开放手术,但应预期多次手术与复杂技术需求。

局限性

  • 仅为4例的病例系列,无对照组,随访与结局按每月及每年分析,结论推广受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ascending and thoracic aortic dissections progress into thoracoabdominal aneurysms 20-40% of the time, due to the initial aortic injury with associated weakness of the aortic wall. The increased firmness of the intimal flap usually results in a collapsed true lumen that does not spontaneously reexpand even with progressive dilatation of the aorta. In an effort to identify a safe and effective treatment path for this complex disease process, we present 4 cases illustrating successful sequential thoracic endovascular aortic repair (TEVAR) and fenestrated endovascular aortic repair (FEVAR). The treatment of these patients with endovascular techniques is less invasive than open conventional operations. However, multiple procedures are required using various complex novel techniques. METHODS: Institutional review board approval was obtained to identify 4 cases between January 2010 and May 2015 of patients with pretreatment hypertension, who initially presented with an aortic dissection. All patients subsequently developed a descending aortic aneurysm and were treated by TEVAR and FEVAR. Monthly and yearly outcomes were analyzed. RESULTS: All procedures concluded with branched visceral vessel patency and no type I endoleaks. One patient required extraction of the retrograde superior mesenteric artery stent placed during the acute phase for visceral reperfusion. Another patient developed acute thromboembolic occlusion of the right common femoral artery requiring emergent revascularization in the immediate postoperative period. CONCLUSIONS: Aortic dissection is the most common cause of death related to aortic pathology. Treatment of type B aortic dissections has traditionally been initially medical therapy unless complications develop. The treatment of subsequent complications has been associated with a high morbidity and mortality rate. However, the advent of evolving endovascular therapies has resulted in the reassessment of how these patients might be handled. This case series illustrates the treatment of expanding chronic thoracoabdominal aortic dissecting aneurysms with a total endovascular approach using various novel techniques.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mantese V, Kunhammed S. Endovascular Aortic Repair for Progressive Chronic Thoracoabdominal Aortic Dissections. Ann Vasc Surg. 2017. PMID: 28341507. doi:10.1016/j.avsg.2016.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。